Dr Thomas Seisen talks about treatment options for metastatic UTUC

Dr Thomas Seisen talks about treatment option...

Up next

2026 update on EAU Guidelines for Non-neurogenic Male LUTS

In this EAU Podcast episode, Prof. Jean-Nicolas Cornu (FR) and Prof. Hashim Hashim (UK) discuss “EAU guidelines updates on Non-neurogenic Male LUTS”. The episode highlights the latest updates to the EAU Guidelines on non-neurogenic male lower urinary tract symptoms, with a focus ...  Show more

Start smart: EU-ACME for young urologists - Becoming a member & using EU-ACME

In Episode 2, “Becoming a member & using EU-ACME” of the series “Start smart: EU-ACME for young urologists”, Prof. Marek Babjuk (CZ), Assoc. Prof. Juan Luis Vásquez (DK), Prof. Giorgio Ivan Russo (IT) and Dr. Loïc Baekelandt (BE) provide practical guidance on joining the programm ...  Show more

Recommended Episodes

Precision Medicine in Chronic Lymphocytic Leukemia (CLL)
EHA Unplugged

Join us for a discussion with Prof Paolo Ghia, MD, PhD, from Università Vita Salute San Raffaele, Milan (Italy), as he explores how precision medicine is transforming CLL treatment. In this episode, discover how precision medicine is used daily in CLL to decide the best managemen ...  Show more

Updates in Canine Melanoma with Dr. Fan
Clinician's Brief: The Podcast

Melanoma is a commonly encountered, often metastatic, disease in canine patients. In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites Dr. Timothy Fan to share advice on the clinical management of melanoma in practice. Dr. Fans offers insights on staging, sur ...

  Show more

Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
BackTable Urology

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ...  Show more

S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Medscape InDiscussion: Multiple Myeloma

Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ...  Show more